The H.Collective
RoundTable
Health Partnerships & Venture Clienting:
Why most health ventures never get a second meeting with pharmaceutical companies
Seats available: 6 / 10What to ExpectOne focused subject.
Curated room.
Most health innovation conversations happen in silos. Founders talk to founders. Pharma talks to pharma. The conversations that would actually move things forward — where both sides speak honestly about what's blocking progress — almost never happen.
The Health Innovation Table is built around one principle: put the right people in the same room, on the same specific topic, with enough structure to go somewhere real. No panel. No pitches. No slides.
A working conversation with Chatham House rules and a deliberately curated mix — founders, pharma innovation leads, investors, and researchers. The kind of room that takes years of relationships to make possible.
Who is it for
Health Ventures
Pinpoint the true barriers to advancement. You already know the partners you want — the problem isn’t the first meeting, it’s the follow-through. Pharma, payers, and health systems aren’t persuaded by polished pitch decks.
They want direct, candid access to the people across the table: no staged presentation, just an honest conversation where they can speak openly.
-
Non-pitch environment. The conversation you can't have at a conference.
-
What blocks progress, heard directly from the people making those decisions.
-
At a similar stage, working through the same commercial challenges.
Pharma & Corporations
Early pipeline insight without procurement hassle. 90 minutes with pre-commercial teams in a private room where candid, off-the-record conversation replaces pitching.
And peer-to-peer dialogue. Corporate innovation and partnership leaders trading real-world lessons on what’s genuinely working and what is not.
-
Pre-commercial ventures curated for relevance in a structured, evaluated context.
-
Peer conversation that almost never happens in a day-to-day.
-
No recording, no public attribution. The condition that makes honesty possible.
Investors
Deal flow, diligence and insights. Seeing how founders navigate a room of critical corporate perspectives reveals far more than multiple separate pitches. Listening to what pharma leaders are prioritising now provides market intelligence that shapes the entire portfolio.
In 90 minutes. With the people building and buying health in Europe & US
-
Pre-commercial ventures before the formal fundraising circuit.
-
What pharma and payers are actually prioritising right now.
-
For founders in and outside the room.
Present at the table
Deliberately balanced approach to the seat allocation.
Payer /
Health System
Pharma & Corporates
Health
Ventures
VC /
Private Equity
The Format
Designed to become meaningful.
Framing
00:00
Context, objectives, and quick introductions. Pre-read distributed five days in advance so participants come prepared and engaged.Opening provocation
00:10
One invited voice, 10 minutes, no slides. A specific counterintuitive perspective. Sets the tone for what follows.Round 1
00:20
Three prepared questions, facilitated. Everyone has a voice. No single person dominates.Round 2
01:00
Focus shifts from diagnosis to what could actually be done differently.Closing
01:25
Three key observations. One final thought from each attendee. Ends sharp — no drag.What you’ll leave with
01
Top Industry Insights from the ecosystem
Whether you're a founder, a pharma lead, or an investor — an honest cross-stakeholder conversation tells you things that months of desk research and pitch meetings don't. You leave knowing something specific you didn't know before.
02
Answer to questions you can't ask directly.
The room gives you 90 minutes with people who are normally on the other side of a negotiation, an evaluation, or a pitch. You can ask what's actually blocking progress — and get a real answer.
03
Session synthesis note in your inbox
A short written summary of what the room discussed — key observations, where people agreed, where they didn't. No names, no direct quotes. Clear enough to share with your team.
Frequently Asked Questions
-
Yes. Chatham House rules, strictly. Nothing said will be recorded or attributed publicly. You'll receive a short synthesis document from Mik afterwards — observations only, no attribution.
-
The full attendee list is shared with confirmed attendees 48 hours before. The composition: 10 people across founders, pharma innovation leads, investors, and researchers. Every seat is curated.
-
Yes, immediately. Email mik@hcollective.co with your company details and a €99 invoice will be sent within the hour. We accept bank transfer or card.
-
Full refund if you cancel more than 48 hours before the session. No refund after that — the seat will have been held and others turned away.
-
Email us and you'll be on the priority list for the next edition. The Health Innovation Table runs quarterly — next session is planned for Q3 2026.
-
Sponsorship for future editions is available. This first session is attendee-funded to protect the independence of the conversation. Reach out: hello@hcollective.co.